{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:04:14Z","timestamp":1784235854071,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000288","name":"The Royal Society","doi-asserted-by":"publisher","award":["INF\\\\R2\\\\202107"],"award-info":[{"award-number":["INF\\\\R2\\\\202107"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","award":["EP\/Y009800\/1"],"award-info":[{"award-number":["EP\/Y009800\/1"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000319","name":"Alzheimer's Research Trust","doi-asserted-by":"publisher","award":["ARUK-PG2023B-010"],"award-info":[{"award-number":["ARUK-PG2023B-010"]}],"id":[{"id":"10.13039\/501100000319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["221633\/Z\/20\/Z"],"award-info":[{"award-number":["221633\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.tjpad.2025.100397","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:02:47Z","timestamp":1764547367000},"page":"100397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Solving the 'Goldilocks problem' in dementia clinical trials with multimodal AI"],"prefix":"10.1016","volume":"13","author":[{"given":"Andrew E.","family":"Welchman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9441-7832","authenticated-orcid":false,"given":"Zoe","family":"Kourtzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjpad.2025.100397_bib0001","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/JAD-215699","article-title":"Alzheimer\u2019s Disease: key insights from two decades of clinical trial failures","volume":"87","author":"Kim","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100397_bib0002","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/joim.12816","article-title":"Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future","volume":"284","author":"Blennow","year":"2018","journal-title":"J Intern Med"},{"key":"10.1016\/j.tjpad.2025.100397_bib0003","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(25)01294-2","article-title":"New landscape of the diagnosis of Alzheimer\u2019s disease","volume":"406","author":"Frisoni","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.tjpad.2025.100397_bib0004","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2318-13-137","article-title":"Characteristics of patients misdiagnosed with Alzheimer\u2019s disease and their medication use: an analysis of the NACC-UDS database","volume":"13","author":"Gaugler","year":"2013","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.tjpad.2025.100397_bib0005","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/WNL.0000000000009058","article-title":"Biological subtypes of Alzheimer disease: a systematic review and meta-analysis","volume":"94","author":"Ferreira","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100397_bib0006","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1002\/alz.13803","article-title":"Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer\u2019s disease trial","volume":"20","author":"Molina-Henry","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100397_bib0007","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: alzheimer\u2019s association workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimer 19s Dement"},{"key":"10.1016\/j.tjpad.2025.100397_bib0008","unstructured":"adni.loni.usc.edu."},{"key":"10.1016\/j.tjpad.2025.100397_bib0009","unstructured":"Besser, L. et al. Version 3 of the National Alzheimer\u2019s Coordinating Center\u2019s Uniform Data Set. www.alzheimerjournal.com (2018)."},{"key":"10.1016\/j.tjpad.2025.100397_bib0010","article-title":"AD Workbench: transforming Alzheimer\u2019s research with secure, global, and collaborative data sharing and analysis","volume":"21","author":"McHugh","year":"2025","journal-title":"Alzheimer 19s Dement"},{"key":"10.1016\/j.tjpad.2025.100397_bib0011","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10654-020-00633-4","article-title":"The dementias platform UK (DPUK) Data Portal","volume":"35","author":"Bauermeister","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.tjpad.2025.100397_bib0012","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jamaneurol.2019.3988","article-title":"Efficacy and safety of lanabecestat for treatment of early and mild Alzheimer disease: the AMARANTH and DAYBREAK-ALZ randomized clinical trials","volume":"77","author":"Wessels","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2025.100397_bib0013","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer\u2019s disease","volume":"378","author":"Egan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tjpad.2025.100397_bib0014","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1812840","article-title":"Randomized trial of verubecestat for prodromal Alzheimer\u2019s disease","volume":"380","author":"Egan","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tjpad.2025.100397_bib0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13195-020-00614-5","article-title":"Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer\u2019s disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study","volume":"12","author":"Novak","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.tjpad.2025.100397_bib0016","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces a\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tjpad.2025.100397_bib0017","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJMoa2304430","article-title":"Two phase 3 trials of Gantenerumab in early Alzheimer\u2019s disease","volume":"389","author":"Bateman","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tjpad.2025.100397_bib0018","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tjpad.2025.100397_bib0019","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.tjpad.2025.100397_bib0020","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1038\/s41467-025-61355-3","article-title":"AI-guided patient stratification improves outcomes and efficiency in the AMARANTH Alzheimer\u2019s Disease clinical trial","volume":"16","author":"Vaghari","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.tjpad.2025.100397_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2020.102199","article-title":"Modelling prognostic trajectories of cognitive decline due to Alzheimer\u2019s disease","volume":"26","author":"Giorgio","year":"2020","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.tjpad.2025.100397_bib0022","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-28795-7","article-title":"A robust and interpretable machine learning approach using multimodal biological data to predict future pathological tau accumulation","volume":"13","author":"Giorgio","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.tjpad.2025.100397_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102725","article-title":"Robust and interpretable AI-guided marker for early dementia prediction in real-world clinical settings","volume":"74","author":"Lee","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.tjpad.2025.100397_bib0024","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s43587-024-00599-y","article-title":"Disease staging of Alzheimer\u2019s disease using a CSF-based biomarker model","volume":"4","author":"Salvad\u00f3","year":"2024","journal-title":"Nat Aging"},{"key":"10.1016\/j.tjpad.2025.100397_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107441","article-title":"Application of uncertainty quantification to artificial intelligence in healthcare: a review of last decade (2013\u20132023)","volume":"165","author":"Seoni","year":"2023","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.tjpad.2025.100397_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038863","article-title":"Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015-2017: a cross-sectional study","volume":"10","author":"Moore","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.tjpad.2025.100397_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-023-00963-z","article-title":"An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized clinical trials","volume":"6","author":"Oikonomou","year":"2023","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.tjpad.2025.100397_bib0028","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13073-022-01102-1","article-title":"Clinical trial design in the era of precision medicine","volume":"14","author":"Fountzilas","year":"2022","journal-title":"Genome Med"},{"key":"10.1016\/j.tjpad.2025.100397_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/S0895-4356(98)00138-3","article-title":"Stratified randomization for clinical trials","volume":"52","author":"Kernan","year":"1999","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.tjpad.2025.100397_bib0030","doi-asserted-by":"crossref","unstructured":"Tu, Y. & Renfro, L.A. Latest developments in \u201cadaptive enrichment\u201d clinical trial designs in oncology. Ther Innov Regul Sci vol. 58 1201\u201313 Preprint at https:\/\/doi.org\/10.1007\/s43441-024-00698-3 (2024).","DOI":"10.1007\/s43441-024-00698-3"},{"key":"10.1016\/j.tjpad.2025.100397_bib0031","first-page":"185","article-title":"Response-adaptive randomization in clinical trials: from myths to practical considerations","volume":"38","author":"Robertson","year":"2023","journal-title":"Stat Sci"},{"key":"10.1016\/j.tjpad.2025.100397_bib0032","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of Aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100397_bib0033","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/jgs.16218","article-title":"Passive digital signature for early identification of Alzheimer\u2019s disease and related dementia","volume":"68","author":"Boustani","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.tjpad.2025.100397_bib0034","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/alz.12748","article-title":"The AHEAD 3-45 study: design of a prevention trial for Alzheimer\u2019s disease","volume":"19","author":"Rafii","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100397_bib0035","unstructured":"FDA. FDA clears first blood test used in diagnosing Alzheimer\u2019s disease. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease (2025)."},{"key":"10.1016\/j.tjpad.2025.100397_bib0036","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1038\/s41591-025-03834-0","article-title":"The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging","volume":"31","author":"Imam","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.tjpad.2025.100397_bib0037","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s40520-018-1087-6","article-title":"Factors influencing attrition in 35 Alzheimer\u2019s disease centers across the USA: a longitudinal examination of the National Alzheimer\u2019s coordinating center\u2019s uniform data set","volume":"31","author":"Burke","year":"2019","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.tjpad.2025.100397_bib0038","doi-asserted-by":"crossref","first-page":"874","DOI":"10.14283\/jpad.2024.136","article-title":"Pre-randomization predictors of study discontinuation in a preclinical Alzheimer\u2019s disease randomized controlled trial","volume":"11","author":"Raman","year":"2024","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100397_bib0039","first-page":"751","article-title":"Recruitment and retention of underrepresented populations in Alzheimer\u2019s disease research: a systematic review","volume":"5","author":"Gilmore-Bykovskyi","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100397_bib0040","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41582-020-0377-8","article-title":"Applications of machine learning to diagnosis and treatment of neurodegenerative diseases","volume":"16","author":"Myszczynska","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.tjpad.2025.100397_bib0041","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/alz.12948","article-title":"Interpretable machine learning for dementia: a systematic review","volume":"19","author":"Martin","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100397_bib0042","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1038\/s41591-024-03118-z","article-title":"AI-based differential diagnosis of dementia etiologies on multimodal data","volume":"30","author":"Xue","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.tjpad.2025.100397_bib0043","first-page":"2023","article-title":"Learning using privileged information: similarity control and knowledge transfer","volume":"16","author":"Vapnik","year":"2015","journal-title":"J Mach Learn Res"},{"key":"10.1016\/j.tjpad.2025.100397_bib0044","unstructured":"https:\/\/www.radar-ad.org."},{"key":"10.1016\/j.tjpad.2025.100397_bib0045","article-title":"A robust harmonization approach for cognitive data from multiple aging and dementia cohorts","volume":"15","author":"Giorgio","year":"2023","journal-title":"Alzheimer 19s Dement: Diagn Assess Dis Monit"},{"key":"10.1016\/j.tjpad.2025.100397_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.patter.2024.101006","article-title":"Recent methodological advances in federated learning for healthcare","volume":"5","author":"Zhang","year":"2024","journal-title":"Patterns"},{"key":"10.1016\/j.tjpad.2025.100397_bib0047","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s43856-023-00356-z","article-title":"The impact of imputation quality on machine learning classifiers for datasets with missing values","volume":"3","author":"Shadbahr","year":"2023","journal-title":"Commun Med"},{"key":"10.1016\/j.tjpad.2025.100397_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.958097","article-title":"Challenges and solutions for transforming health ecosystems in low- and middle-income countries through artificial intelligence","volume":"9","author":"L\u00f3pez","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.tjpad.2025.100397_bib0049","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-022-00700-y","article-title":"Artificial intelligence for strengthening healthcare systems in low- and middle-income countries: a systematic scoping review","volume":"5","author":"Ciecierski-Holmes","year":"2022","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.tjpad.2025.100397_bib0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1109\/JBHI.2016.2636665","article-title":"Deep learning for health informatics","volume":"21","author":"Ravi","year":"2017","journal-title":"IEEE J Biomed Health Inf"},{"key":"10.1016\/j.tjpad.2025.100397_bib0051","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev-statistics-040120-030919","article-title":"Interpretable machine learning for discovery: statistical challenges and opportunities","volume":"11","author":"Allen","year":"2024","journal-title":"Annu Rev Stat Appl"},{"key":"10.1016\/j.tjpad.2025.100397_bib0052","series-title":"Proceedings of the 37th International Conference on Machine Learning","first-page":"5338","article-title":"Concept bottleneck models","author":"Wei Koh","year":"2020"},{"key":"10.1016\/j.tjpad.2025.100397_bib0053","series-title":"Proceedings of the 31st International Conference on Neural Information Processing Systems (NIPS\u201917) 6000\u20136010","article-title":"Attention is all you need","author":"Vaswani","year":"2017"},{"key":"10.1016\/j.tjpad.2025.100397_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.artint.2022.103822","article-title":"Logic Explained Networks","volume":"314","author":"Ciravegna","year":"2023","journal-title":"Artif Intell"},{"key":"10.1016\/j.tjpad.2025.100397_bib0055","series-title":"Improving representation in clinical trials and research","author":"Bibbins-Domingo","year":"2022"},{"key":"10.1016\/j.tjpad.2025.100397_bib0056","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13063-025-08769-y","article-title":"Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review","volume":"26","author":"Alarc\u00f3n Garavito","year":"2025","journal-title":"Trials"},{"key":"10.1016\/j.tjpad.2025.100397_bib0057","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3233\/JAD-201209","article-title":"Ethnic differences in dementia risk: a systematic review and meta-analysis","volume":"80","author":"Shiekh","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2025.100397_bib0058","first-page":"510","article-title":"Racial and ethnic differences in trends in dementia prevalence and risk factors in the United States","volume":"4","author":"Chen","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100397_bib0059","unstructured":"Smith, J., Holder, A., Kamaleswaran, R. & Xie, Y. Detecting algorithmic bias in medical-AI models using trees. ArXiv 2312.02959 http:\/\/arxiv.org\/abs\/2312.02959 (2024)."},{"key":"10.1016\/j.tjpad.2025.100397_bib0060","unstructured":"Abroshan, M. et al. Safe AI for health and beyond \u2013 Monitoring to transform a health service. (2023)."},{"key":"10.1016\/j.tjpad.2025.100397_bib0061","unstructured":"Good Machine Learning Practice for Medical Device Development: Guiding Principles. https:\/\/www.fda.gov\/medical-devices\/software-medical-device-samd\/good-machine-learning-practice-medical-device-development-guiding-principles (2021)."}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725003395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725003395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:13:08Z","timestamp":1784232788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725003395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2274580725003395"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100397","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Solving the 'Goldilocks problem' in dementia clinical trials with multimodal AI","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100397"}}